Targeting microbiota in dietary obesity management: a systematic review on randomized control trials in adults
Authors:
- Marina CaputoMCMarina Caputo
- Stella PigniSPStella Pigni
- Valentina AntoniottiVAValentina Antoniotti
- Emanuela AgostiEAEmanuela Agosti
- Alice CaramaschiACAlice Caramaschi
- Alessandro AntonioliAAAlessandro Antonioli
- Gianluca AimarettiGianluca Aimaretti
- Marcello ManfrediMarcello Manfredi
- Elisa BonaElisa Bona
- Flavia ProdamFPFlavia Prodam
Open Access
- 16 June 2022
- journal article
- review article
- Published by Taylor & Francis in Critical Reviews in Food Science and Nutrition
- Vol. 63 (33) , 11449-11481
Abstract
Obesity is an alarming public health problem. Tailored nutritional therapy is advisable since emerging evidence on complex cross-talks among multifactorial agents. In this picture, the gut microbiota is highly individualized and intricately dependent on dietary patterns, with implications for obesity management. Most of the papers on the topic are observational and often conflicting. This review aimed to systematically organize the body of evidence on microbiota deriving from dietary trials in adult obesity giving the most certain phylogenetic, and metabolomic signatures in relation to both the host metabolism and phenotype changes published until now. We retrieved 18 randomized control trials on 1385 subjects with obesity who underwent several dietary interventions, including standard diet and healthy dietary regimens. Some phyla and species were more related to diets rich in fibers and others to healthy diets. Weight loss, metabolism improvements, inflammatory markers decrease were specifically related to different microorganisms or functions. The Prevotella/Bacteroides ratio was one of the most reported predictors. People with the burden of obesity comorbidities had the most significant taxonomic changes in parallel with a general improvement. These data emphasize the possibility of using symbiotic approaches involving tailored diets, microbiota characteristics, and maybe drugs to treat obesity and metabolic disorders. We encourage Authors to search for specific phylogenetic associations beyond a too generally reported Firmicutes/Bacteroides ratio.Keywords
Funding Information
- Ministry of Education, Universities, and Research: Grant PRIN (2020NCKXBR_004)
- Ministry of Education, Universities, and Research, Department of Excellence
This publication has 85 references indexed in Scilit:
- Functional Metagenomics Reveals Novel Pathways of Prebiotic Breakdown by Human Gut BacteriaPLOS ONE, 2013
- High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic healthThe American Journal of Clinical Nutrition, 2011
- Fermentation potential of the gut microbiome: implications for energy homeostasis and weight managementNutrition Reviews, 2011
- Dominant and diet-responsive groups of bacteria within the human colonic microbiotaThe ISME Journal, 2010
- Effect of a Mediterranean Diet Supplemented With Nuts on Metabolic Syndrome StatusArchives of internal medicine (1960), 2008
- Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in FecesApplied and Environmental Microbiology, 2007
- Human gut microbes associated with obesityNature, 2006
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Phenotypic and Phylogenetic Characterization of Some Eubacterium-Like Isolates Containing a Novel Type B Wall Murein from Human Feces: Description of Holdemania filiformis gen. nov., sp. nov.International Journal of Systematic and Evolutionary Microbiology, 1997
- The control and consequences of bacterial fermentation in the human colonJournal of Applied Bacteriology, 1991